Evidence map›Paper›PMID 40098532›Full record

ArticleFuture oncology (London, England)2025

Improving lung cancer decision-making using a conversation tool (iDECIDE): a stepped wedge pragmatic clinical trial.

Natalie Disher, Nathan F Dieckmann, James R Case, Felipe Rubim, Karen B Eden, Sara E Golden, Daniel D Matlock, Clifford Coleman, Karen S Lyons, Somnath Saha and 3 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Future oncology (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05407168 (Improving Decision-Making Encounters in Lung Cancer), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05407168 narecruitingnot on this map

Improving Decision-Making Encounters in Lung Cancer (I DECide) II: A Randomized Control Trial Of A Low-Literacy Conversation Tool

TypeinterventionalSponsorOHSU Knight Cancer InstituteRan2022 to 2027Enrolled300ConditionsLung CarcinomaArmsBest Practice, Health Promotion and Education, Questionnaire Administration
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Natalie DisherCenter to Improve Veteran Involvement in Care, VA Portland Health Care System (VAPORHCS), Portland, OR, USA.
Nathan F DieckmannDivision of Psychology, School of Medicine, OHSU, Portland, OR, USA.
James R CaseMongoose Projects Incorporated, Corvallis, OR, USA.
Felipe RubimCenter to Improve Veteran Involvement in Care, VA Portland Health Care System (VAPORHCS), Portland, OR, USA.
Karen B EdenDepartment of Medical Informatics and Clinic Epidemiology, OHSU, Portland, OR, USA.
Sara E GoldenCenter to Improve Veteran Involvement in Care, VA Portland Health Care System (VAPORHCS), Portland, OR, USA.
Daniel D MatlockDivision of Geriatric Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Clifford ColemanDepartment of Family Medicine, Oregon Health & Science University, Portland, OR, USA.
Karen S LyonsConnell School of Nursing, Boston College, Chestnut Hill, MA, USA.
Somnath SahaCenter to Improve Veteran Involvement in Care, VA Portland Health Care System (VAPORHCS), Portland, OR, USA.
Christopher G SlatoreCenter to Improve Veteran Involvement in Care, VA Portland Health Care System (VAPORHCS), Portland, OR, USA.
Kelly C VranasCenter to Improve Veteran Involvement in Care, VA Portland Health Care System (VAPORHCS), Portland, OR, USA.
Donald R SullivanCenter to Improve Veteran Involvement in Care, VA Portland Health Care System (VAPORHCS), Portland, OR, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is a leading cause of cancer-related mortality. However, few treatment decision-making resources exist. In this study, we evaluate a low literacy lung cancer treatment conversation tool to enhance shared decision-making (SDM). The Improving Decision-Making Encounters in Lung Cancer (iDECIDE) pragmatic, stepped-wedge cluster randomized trial evaluates the effectiveness of a conversation tool for patients with lung cancer. Our primary outcome is SDM, a multifaceted outcome consisting of decisional conflict (DCS), decision self-efficacy (DSES), satisfaction with communication (COMRADE), and assessment of lung cancer knowledge. SDM is assessed 2 weeks, 3 months, and 6 months after patients' treatment decision-making encounter. Each measure within the primary outcome will be assessed separately. We began recruiting patients in 2022 from four health care centers and will conduct outcome assessments at four timepoints over 6 months. We aim to recruit 230 patients by 2025. We seek to address the gaps in NSCLC decision-making support using an innovative trial design to determine whether our conversation tool improves SDM and other patient-centered outcomes.Clinical Trial Registration: NCT05407168 (clinicaltrials.gov).

Indexed as

Decision Making, SharedLung NeoplasmsCommunicationFemaleHumansMalePatient ParticipationPragmatic Clinical Trials as TopicSelf Efficacydecision aidDecision-support techniqueslung neoplasmnon-small cell lung cancershared decision-making

Identifiers

PMID40098532
PMCPMC11988236

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.